Inari Medical Pre-Tax Profit Margin 2019-2023 | NARI
Inari Medical pre-tax profit margin from 2019 to 2023. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Inari Medical Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2023-12-31 | $0.49B | $0.01B | 1.01% |
| 2023-09-30 | $0.47B | $0.00B | 0.64% |
| 2023-06-30 | $0.44B | $-0.01B | -2.73% |
| 2023-03-31 | $0.41B | $-0.02B | -5.81% |
| 2022-12-31 | $0.38B | $-0.03B | -6.77% |
| 2022-09-30 | $0.36B | $-0.02B | -5.29% |
| 2022-06-30 | $0.34B | $-0.01B | -3.87% |
| 2022-03-31 | $0.31B | 0 | 0.00% |
| 2021-12-31 | $0.28B | $0.01B | 3.99% |
| 2021-09-30 | $0.24B | $0.02B | 6.61% |
| 2021-06-30 | $0.21B | $0.03B | 12.02% |
| 2021-03-31 | $0.17B | $0.02B | 10.00% |
| 2020-12-31 | $0.14B | $0.01B | 9.29% |
| 2020-06-30 | $0.07B | 0 | 0.00% |
| 2020-03-31 | $0.05B | $0.00B | 5.88% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $2.207B | $0.494B |
| Inari Medical, Inc. is a commercial-stage medical device company committed toward developing products to treat and change the lives of patients suffering from venous diseases. Its initial product offering comprises 2 minimally-invasive, novel catheter-based mechanical thrombectomy devices. It built its products purposely on the basis of the specific characteristics of the venous system and the treatment of the two distinct indications of venous thromboembolism or VTE (deep vein thrombosis and pulmonary embolism/ PE). Its FlowTriever product is the first thrombectomy system, which is FDA-cleared, used for the treatment of PE. Its advanced systems & processes to control the key relationships between its sales representatives and treating physicians like cardiologists, radiologists, helps it to quickly iterate products, launch and execute physician education and training programs and scale its sales organization. The company markets and sells its products to hospitals across the U.S. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $218.237B | 26.44 |
| Intuitive Surgical (ISRG) | United States | $132.348B | 79.73 |
| DexCom (DXCM) | United States | $54.655B | 83.14 |
| Edwards Lifesciences (EW) | United States | $52.976B | 34.51 |
| IQVIA Holdings (IQV) | United States | $42.467B | 25.19 |
| IDEXX Laboratories (IDXX) | United States | $40.633B | 48.58 |
| Alcon (ALC) | Switzerland | $38.876B | 28.67 |
| STERIS (STE) | Ireland | $19.915B | 23.57 |
| Waters (WAT) | United States | $18.288B | 26.24 |
| Hologic (HOLX) | United States | $17.772B | 19.61 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.481B | 0.00 |
| ShockWave Medical (SWAV) | United States | $12.303B | 85.01 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.860B | 14.65 |
| Sysmex ADR (SSMXY) | Japan | $9.975B | 31.28 |
| Teleflex (TFX) | United States | $9.736B | 15.29 |
| Penumbra (PEN) | United States | $7.965B | 98.32 |
| Masimo (MASI) | United States | $7.156B | 40.13 |
| Globus Medical (GMED) | United States | $6.819B | 21.62 |
| Glaukos (GKOS) | United States | $5.024B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.724B | 22.50 |
| LivaNova (LIVN) | United Kingdom | $2.973B | 19.61 |
| TransMedics (TMDX) | United States | $2.920B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.687B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.570B | 17.63 |
| Nihon Kohden (NHNKY) | Japan | $2.380B | 20.13 |
| Tandem Diabetes Care (TNDM) | United States | $2.296B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.233B | 9.16 |
| RxSight (RXST) | United States | $1.919B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.689B | 0.00 |
| Veracyte (VCYT) | United States | $1.462B | 0.00 |
| OPKO Health (OPK) | United States | $0.850B | 0.00 |
| Artivion (AORT) | United States | $0.835B | 96.52 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.825B | 15.26 |
| Paragon 28 (FNA) | United States | $0.744B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.712B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.691B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.636B | 0.00 |
| SiBone (SIBN) | United States | $0.586B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.549B | 18.65 |
| IRadimed (IRMD) | United States | $0.525B | 30.49 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.490B | 0.00 |
| Nevro (NVRO) | United States | $0.426B | 0.00 |
| NeuroPace (NPCE) | United States | $0.373B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.370B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.369B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.339B | 11.42 |
| CVRx (CVRX) | United States | $0.311B | 0.00 |
| AxoGen (AXGN) | United States | $0.285B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.275B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.255B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.232B | 0.00 |
| Accuray (ARAY) | United States | $0.216B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.190B | 0.00 |
| 908 Devices (MASS) | United States | $0.183B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.182B | 9.81 |
| Alpha Tau Medical (DRTS) | Israel | $0.167B | 0.00 |
| Inogen (INGN) | United States | $0.153B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.144B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.134B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.112B | 0.00 |
| Neuronetics (STIM) | United States | $0.106B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.100B | 0.00 |
| Envoy Medical (COCH) | United States | $0.099B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.093B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.075B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.070B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.063B | 0.00 |
| Hyperfine (HYPR) | United States | $0.060B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.058B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.055B | 111.00 |
| Vasomedical (VASO) | United States | $0.052B | 9.33 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| InspireMD (NSPR) | Israel | $0.045B | 0.00 |
| DarioHealth (DRIO) | United States | $0.044B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.040B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.040B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.040B | 0.00 |
| LENSAR (LNSR) | United States | $0.039B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.038B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.032B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.024B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.020B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.017B | 0.00 |
| PAVmed (PAVM) | United States | $0.016B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.015B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.015B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.012B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.005B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.004B | 0.00 |
| Dynatronics (DYNT) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |